收藏切换
Analysis on the curative effects of secukinumab combined with topical shikonin in the treatment of recurrent moderate-to-severe plaque psoriasis
收藏切换
Xiongbo YANG, Yue WANG*, Jing YANG, Haitao FENG
World Clinical Drug | 2022, 43(12) : 1568 - 1573
Less
收藏切换
World Clinical Drug | 2022, 43(12): 1568-1573
• Article •
Analysis on the curative effects of secukinumab combined with topical shikonin in the treatment of recurrent moderate-to-severe plaque psoriasis
Full
Xiongbo YANG, Yue WANG*, Jing YANG, Haitao FENG
Affiliations
  • Department of Dermatology and Venereology, Chongqing University Three Gorges Hospital, Chongqing 404000, China
Published: 2022-12-10 doi: 10.13683/j.wph.2022.12.008
Outline
收藏切换
Objective

To analyze the effects of secukinumab combined with topical shikonin on immune inflammatory indexes and skin barrier function in patients with recurrent moderate-to-severe plaque psoriasis.

Methods

A total of 70 patients with recurrent moderate-to-severe plaque psoriasis in our hospital from January 2020 to January 2022 were selected and divided into observation group and control group according to the random number table method, with 35 cases in each group. Both groups received conventional treatment, and the control group was added with secukinumab, and the observation group was added with secukinumab and shikonin. The two groups were treated continuously for 12 weeks, the curative effect was evaluated and the occurrence of adverse reactions were recorded. Changes in psoriasis area and severity index (PASI) score, neutrophil-to-lymphocyte ratio (NLR), dermatological quality of life index (DLQI) score, serum tumor necrosis factor (TNF)-α, interleukin (IL)-17, IL-23 levels, stratum corneum water content and sebum content before and after treatment were analyzed.

Results

The total effective rate of the observation group was 94.59% higher than that of the control group (74.29%), the difference was significant (P<0.05). After treatment, the PASI score, DLQI score and NLR of the observation group were lower than those of the control group (P<0.05). Compared with the control group, the water content and sebum content in the stratum corneum in the observation group were higher, and serum levels of TNF-α, IL-17 and IL-23 were lower (P<0.05).

Conclusion

Secukinumab combined with topical shikonin is effective in the treatment of recurrent moderate-to-severe plaque psoriasis. It can effectively regulate immune inflammatory indexes, improve skin barrier function, alleviate the disease condition, improve the quality of life of patients, and ensure the safety.

secukinumab  /  shikonin  /  psoriasis  /  inflammatory factor  /  safety
杨雄波, 王玥, 杨靖, 封海涛. 司库奇尤单抗联合紫草素对复发性中重度斑块型银屑病的疗效分析. 世界临床药物, 2022 , 43 (12) : 1568 -1573 . DOI: 10.13683/j.wph.2022.12.008
Xiongbo YANG, Yue WANG, Jing YANG, Haitao FENG. Analysis on the curative effects of secukinumab combined with topical shikonin in the treatment of recurrent moderate-to-severe plaque psoriasis[J]. World Clinical Drug, 2022 , 43 (12) : 1568 -1573 . DOI: 10.13683/j.wph.2022.12.008
Year 2022 volume 43 Issue 12
12
3
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2022.12.008
  • Receive Date:2022-07-19
  • Online Date:2026-11-18
  • Published:2022-12-10
Article Data
Affiliations
History
  • Received:2022-07-19
  • Revised:2022-12-11
Funding
Affiliations
    Department of Dermatology and Venereology, Chongqing University Three Gorges Hospital, Chongqing 404000, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.12.008
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT